Eric Scott

Marianne Brodmann, MD, Prof is a vascular specialist at the Medical University of Graz, Austria. She has been trained in Internal Medicine at the University Hospital of Graz and her main focus, after specializing in Vascular Medicine (Angiology), is doing peripheral endovascular procedures. She is involved in many trials dealing with new endovascular techniques in both claudicants as well as CLI patients.

Dr. Sameh Sayfo is an interventional cardiologist and peripheral endovascular specialist based in Plano, Texas, affiliated with Baylor Scott & White Health. His practice focuses on complex coronary interventions, peripheral and carotid artery disease, endovascular aortic repair, and venous thromboembolic disease, with particular expertise in chronic venous occlusion, percutaneous transmural arterial bypass (PTAB), and minimally invasive carotid stenting. He serves as Director of the Pulmonary Embolism Response Team and Program Director of the Peripheral Endovascular Fellowship at Baylor Scott & White The Heart Hospital–Plano, Vice Chair of the PERT Consortium Education Committee, a contributor to the Vascular Disease Council at Society for Cardiovascular Angiography & Interventions, and Clinical Assistant Professor at Texas A&M University School of Medicine. Beyond his clinical and academic roles, Dr. Sayfo is a host for the BackTable Cardiology podcast, sharing insights on advanced cardiovascular techniques and innovative procedural outcomes with the global medical community

Professor Varcoe is a vascular surgeon at Sydney’s Prince of Wales Hospital where he is director of surgery, anaesthetics and perioperative services for the South Eastern Sydney Local Health District. He is also director of the Prince of Wales operating theatres and of the Vascular Institute, one of Australia’s most prestigious clinical trials centres. His clinical practice specialises in the minimally invasive treatment of aortic conditions, carotid disease and the full gamut of occlusive arterial disease of the lower limb for which he is internationally renowned.

He has a strong academic interest in novel stent and anastomotic technologies, the investigation of intimal hyperplasia, and cellular mechanisms, and has the first-in-man experience with the Absorb bioresorbable stent technology applied below-the-knee. In 2015, he completed his PhD and in 2020 he completed a Masters in Clinical Epidemiology focussing on clinical trial design and biostatistics at the University of Sydney.

He is a Professor at the University of New South Wales where he teaches regularly. He is founder and course director of the New South Wales Vascular meeting and the VERVE symposium, the largest annual endovascular summit in Australasia.

He is a member of numerous learned societies, has published more than 130 peer reviewed manuscripts, five book chapters, is an invited reviewer for multiple leading journal in the field of vascular medicine, intervention and science, is on the editorial board of several of those same journals. He has been invited to speak both nationally and internationally on more than 300 individual occasions.

Eric Scott, MD is a board-certified vascular surgeon at the Iowa Clinic in Des Moines, Iowa where he began practice in 2008. He performs both arterial and venous procedures and has special interest in endovascular therapies for PAD and treatment of critical limb ischemia. Outside of the hospital, he enjoys spending time with his wife and three sons biking, skiing, travleing, and playing tennis.

Michael Siah, M.D., is an Associate Professor in the Department of Surgery at UT Southwestern Medical Center. He is a board-certified vascular surgeon and has been practicing at UT Southwestern since 2019.

Dr. Siah earned his medical degree at the University of Hawaii’s John A. Burns School of Medicine and completed a residency in vascular surgery at Georgetown University Hospital/Washington Hospital Center. He has delivered a number of presentations and published several academic articles and book chapters.

Additionally, he is Director of the Limb Salvage Program in the Division of Vascular and Endovascular Surgery at UT Southwestern. His primary clinical focus is on therapies for peripheral vascular disease, diabetic limb salvage, complex deep venous disease, and carotid disease.

Tim Wittig is a senior resident in the Department of Angiology at University Hospital Leipzig, where he combines clinical practice with active involvement in translational and clinical research. His primary focus lies in the field of interventional angiology, with particular emphasis on the development of differentiated and patient-specific treatment strategies for peripheral artery disease (PAD). His research interests include the optimization of endovascular procedures through advanced vessel preparation techniques and the integration of cutting-edge vascular imaging modalities to enhance diagnostic precision and procedural outcomes. Through his work, he aims to contribute to the refinement of minimally invasive therapies and improve long-term vascular health in patients with complex peripheral arterial disease.